Kailera Therapeutics (KLRA) Stock Forecast & Price Target

KLRA$13.27+0.06 +0.45%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$1.72BEnterprise value$1.65BRevenue (TTM)$0Market position—

Score

72
Bullish
Value
70
Quality
47
Growth
100

Kailera Therapeutics, Inc. price target

KLRA
Low$36.00
Average$42.00
High$48.00
Upside vs current price+216.5%

The average target of $42.00 is +216.5% versus the current KLRA price of $13.27.

Kailera Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy6
Hold0
Sell0
Strong sell0
ConsensusBuy

7 analysts cover KLRA.

Kailera Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Kailera Therapeutics, Inc. keeps 2026 EPS $-3.92, 2027 EPS $-3.86, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-3.92—
2027$-3.86—

Is Kailera Therapeutics, Inc. a buy or sell?

Of the 7 analysts covering Kailera Therapeutics, Inc., 7 rate it a buy (1 strong buy and 6 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The KLRA consensus label is Buy, beside 7 buy-side ratings and 0 sell-side ratings.

The average target of $42.00 implies +216.5% versus the current price of $13.27.

the Kailera Therapeutics, Inc. closes with 7 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Kailera Therapeutics, Inc. forecast

Between the KLRA low of $36.00 and the high of $48.00, the average target is $42.00.

From today's $13.27 print, the KLRA average target is +216.5% away.

Most of the KLRA coverage agrees: 7 of 7 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

Earnings estimates for KLRA are rising: 2026 $-3.92, then 2027 $-3.86.

KLRA coverage is thin at 7 analysts, and one revision moves the average.

Kailera Therapeutics, Inc. forecast questions

What is the KLRA price target?

The published range for KLRA is $36.00 to $48.00, with an average of $42.00. That average is +216.5% versus the current price of $13.27.

Is Kailera Therapeutics, Inc. a buy or sell?

Of the 7 analysts covering Kailera Therapeutics, Inc., 7 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for KLRA is 7 on the buy side, 0 at hold, and 0 on the sell side.

What is the EPS estimate for Kailera Therapeutics, Inc.?

Analyst EPS estimates for Kailera Therapeutics, Inc.: 2026 $-3.92, 2027 $-3.86.

What is the revenue estimate for Kailera Therapeutics, Inc.?

No revenue estimate with at least 3 analysts is on file for Kailera Therapeutics, Inc..

How many analysts cover KLRA?

7 analysts cover KLRA. Their consensus on KLRA is Buy, across those 7.

KLRA price $13.27 +0.06 +0.45%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener